170 related articles for article (PubMed ID: 35949145)
41. A universal DNA aptamer as an efficient inhibitor against spike-protein/hACE2 interactions.
Silwal AP; Jahan R; Thennakoon SKS; Arya SP; Postema RM; Vander Ark EC; Tan X
Chem Commun (Camb); 2022 Jul; 58(58):8049-8052. PubMed ID: 35748608
[TBL] [Abstract][Full Text] [Related]
42. A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein.
Civit L; Moradzadeh N; Jonczyk A; Neckermann P; Asbach B; Peterhoff D; Wagner R; Famulok M; Mayer G; Kjems J; Valero J
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731860
[TBL] [Abstract][Full Text] [Related]
43. Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding.
Bozdaganyan ME; Shaitan KV; Kirpichnikov MP; Sokolova OS; Orekhov PS
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215888
[TBL] [Abstract][Full Text] [Related]
44. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
45. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
46. Antibody cocktail effective against variants of SARS-CoV-2.
Liang KH; Chiang PY; Ko SH; Chou YC; Lu RM; Lin HT; Chen WY; Lin YL; Tao MH; Jan JT; Wu HC
J Biomed Sci; 2021 Nov; 28(1):80. PubMed ID: 34814920
[TBL] [Abstract][Full Text] [Related]
47. Proof-of-concept for speedy development of rapid and simple at-home method for potential diagnosis of early COVID-19 mutant infections using nanogold and aptamer.
Ellipilli S; Wang H; Lee WJ; Shu D; Guo P
Nanomedicine; 2022 Sep; 45():102590. PubMed ID: 35905841
[TBL] [Abstract][Full Text] [Related]
48. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
Ge J; Zhang S; Zhang L; Wang X
Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
[TBL] [Abstract][Full Text] [Related]
49. In vitro selection and identification of ssDNA aptamers recognizing the Ras protein.
Wang ZW; Wu HB; Mao ZF; Hu XP; Zhang H; Hu ZP; Ren ZL
Mol Med Rep; 2014 Sep; 10(3):1481-8. PubMed ID: 24938205
[TBL] [Abstract][Full Text] [Related]
50. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.
Hussain A; Hasan A; Nejadi Babadaei MM; Bloukh SH; Chowdhury MEH; Sharifi M; Haghighat S; Falahati M
Biomed Pharmacother; 2020 Oct; 130():110559. PubMed ID: 32768882
[TBL] [Abstract][Full Text] [Related]
51. Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1.
Yang G; Li Z; Mohammed I; Zhao L; Wei W; Xiao H; Guo W; Zhao Y; Qu F; Huang Y
Signal Transduct Target Ther; 2021 Jun; 6(1):227. PubMed ID: 34112756
[No Abstract] [Full Text] [Related]
52. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
[TBL] [Abstract][Full Text] [Related]
53. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
54. Aptamer Sandwich Lateral Flow Assay (AptaFlow) for Antibody-Free SARS-CoV-2 Detection.
Yang LF; Kacherovsky N; Panpradist N; Wan R; Liang J; Zhang B; Salipante SJ; Lutz BR; Pun SH
Anal Chem; 2022 May; 94(20):7278-7285. PubMed ID: 35532905
[TBL] [Abstract][Full Text] [Related]
55. Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein.
Verma S; Patil VM; Gupta MK
Drug Discov Today; 2022 Oct; 27(10):103312. PubMed ID: 35787481
[TBL] [Abstract][Full Text] [Related]
56. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984
[TBL] [Abstract][Full Text] [Related]
57. Model of the SARS-CoV-2 Virus for Development of a DNA-Modified, Surface-Enhanced Raman Spectroscopy Sensor with a Novel Hybrid Plasmonic Platform in Sandwich Mode.
Samodelova MV; Kapitanova OO; Meshcheryakova NF; Novikov SM; Yarenkov NR; Streletskii OA; Yakubovsky DI; Grabovenko FI; Zhdanov GA; Arsenin AV; Volkov VS; Zavyalova EG; Veselova IA; Zvereva MI
Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140152
[TBL] [Abstract][Full Text] [Related]
58. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2.
Sakib MMH; Nishat AA; Islam MT; Raihan Uddin MA; Iqbal MS; Bin Hossen FF; Ahmed MI; Bashir MS; Hossain T; Tohura US; Saif SI; Jui NR; Alam M; Islam MA; Hasan MM; Sufian MA; Ali MA; Islam R; Hossain MA; Halim MA
Comput Biol Med; 2021 Sep; 136():104759. PubMed ID: 34403938
[TBL] [Abstract][Full Text] [Related]
59. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
60. A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism.
Schmitz A; Weber A; Bayin M; Breuers S; Fieberg V; Famulok M; Mayer G
Angew Chem Weinheim Bergstr Ger; 2021 Apr; 133(18):10367-10373. PubMed ID: 34230708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
